Hospital Inpatient Services Modernization Act
SB 2237, the Hospital Inpatient Services Modernization Act, would extend the federal Acute Hospital Care at Home waiver flexibilities under Medicare from 2025 to 2030. These flexibilities allow eligible hospitals to furnish certain acute inpatient-level services in patients’ homes instead of in a traditional hospital setting, subject to the program’s waiver framework.
The bill also requires the Secretary of Health and Human Services to conduct a new study by September 30, 2028, and report to the House Ways and Means Committee and Senate Finance Committee. The study must examine how hospitals decide who qualifies for the initiative and compare care quality, outcomes, readmissions, mortality, length of stay, infection rates, staffing models, transfers, post-acute discharges, service intensity, costs, caregiver involvement, and socioeconomic characteristics of patients treated at home versus in hospitals. It also directs analysis of selection bias and other factors that could affect the reliability of the findings.
The bill would amend section 1866G of the Social Security Act, extending the statutory authority for acute hospital care at home waivers and expanding the federal reporting requirements tied to that authority. In practical terms, it would preserve Medicare flexibility for participating hospitals to continue delivering hospital-level care in the home through 2030, while requiring HHS to produce a more detailed evidence review on clinical, operational, and equity-related outcomes. The measure affects Medicare-participating hospitals, patients eligible for home-based acute care, caregivers, and federal policymakers evaluating whether the model should continue or be modified after the waiver period.
Based on the bill text and available context, the measure appears generally favorable and bipartisan in tone. It was introduced by Senator Scott with cosponsors from both parties, suggesting broad interest in preserving and evaluating the hospital-at-home model. No committee transcript or recorded vote is available here, so there is no direct evidence of opposition in the provided materials. The inclusion of a new study requirement also indicates an effort to pair extension with oversight rather than making the flexibility permanent without further review.
The main points of potential contention are likely to center on whether hospital-at-home care provides outcomes equivalent to inpatient care, how costs compare, and whether the model is safe and scalable across different patient populations. The bill specifically anticipates concerns about selection bias, staffing composition, transfers back to the hospital, and differences in outcomes for patients with varying socioeconomic backgrounds, including dual-eligible beneficiaries. Stakeholders who favor the program may emphasize access, convenience, and cost savings, while skeptics may question clinical comparability, data quality, and whether the waiver should be extended before more evidence is available.